MDB

MongoDB reported strong Q2 fiscal 2027 results with 17% year-over-year growth in $100K+ ARR customers and 29% Atlas revenue growth. The company raised its full-year Atlas growth outlook to 27%, driven by enterprise adoption, multiproduct usage, and AI-driven demand. However, MongoDB faces competition from Amazon's DocumentDB and Microsoft's Azure Cosmos DB, while its stock has underperformed the tech sector year-to-date.

MongoDB (MDB) shares have declined 11.1% year-to-date, underperforming the tech sector and trailing competitors like Datadog, Snowflake, and Nutanix. However, analysts view this weakness as a buying opportunity, citing strong Atlas cloud database growth (29% YTD), record incremental revenues of $127 million, expanding AI capabilities with 30% of Atlas ARR from AI use cases, and robust Enterprise Advanced sales growth of 36%. Positive earnings estimate revisions and improving profitability support long-term investment appeal despite premium valuation concerns.

MongoDB (MDB) has been added to the Zacks Rank #1 (Strong Buy) list as of September 24, 2026. The database software company has seen 12 analysts revise earnings estimates higher in the last 60 days, with consensus estimates increasing to $6.50 per share.

MDB is forecasted to achieve 30.8% earnings growth and 22.4% sales growth, with an average earnings surprise of 27.5%. The stock has outperformed the S&P 500 over the past four weeks.